Development of pharmacotherapies for drug addiction: a Rosetta Stone approach
- 1 June 2009
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Drug Discovery
- Vol. 8 (6), 500-515
- https://doi.org/10.1038/nrd2828
Abstract
No abstract availableKeywords
This publication has 151 references indexed in Scilit:
- Cue-induced reinstatement of alcohol-seeking behavior is associated with increased ERK1/2 phosphorylation in specific limbic brain regions: Blockade by the mGluR5 antagonist MPEPNeuropharmacology, 2008
- The α1 adrenergic receptor antagonist prazosin reduces heroin self-administration in rats with extended access to heroin administrationPharmacology Biochemistry and Behavior, 2008
- Effect of positive and negative affective stimuli and beverage cues on measures of craving in non treatment-seeking alcoholicsPsychopharmacology, 2008
- A Role for Brain Stress Systems in AddictionNeuron, 2008
- α1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanolAlcohol, 2008
- An Evaluation of μ-Opioid Receptor (OPRM1) as a Predictor of Naltrexone Response in the Treatment of Alcohol DependenceArchives of General Psychiatry, 2008
- CRF1 receptor antagonists attenuate escalated cocaine self-administration in ratsPsychopharmacology, 2007
- α1-Noradrenergic system role in increased motivation for cocaine intake in rats with prolonged accessEuropean Neuropsychopharmacology, 2007
- ‘Nicotine deprivation effect' in rats with intermittent 23-hour access to intravenous nicotine self-administrationPharmacology Biochemistry and Behavior, 2007
- Corticotropin-Releasing Factor 1 Antagonists Selectively Reduce Ethanol Self-Administration in Ethanol-Dependent RatsBiological Psychiatry, 2007